Back to Search
Start Over
Patient-reported outcomes from a phase 3 study of baricitinib versus placebo or adalimumab in rheumatoid arthritis: secondary analyses from the RABEAM study.
- Source :
- Annals of the Rheumatic Diseases; Nov2017, Vol. 76 Issue 11, p1853-1861, 9p, 3 Charts, 3 Graphs
- Publication Year :
- 2017
Details
- Language :
- English
- ISSN :
- 00034967
- Volume :
- 76
- Issue :
- 11
- Database :
- Complementary Index
- Journal :
- Annals of the Rheumatic Diseases
- Publication Type :
- Academic Journal
- Accession number :
- 125575523
- Full Text :
- https://doi.org/10.1136/annrheumdis-2017-211259